Atticus Pharma
2 known investors
Atticus Pharma develops immunodermatology therapeutics using patented sustained-release technology for enhanced delivery to the viable epidermis. The company focuses on dermatological treatments leveraging its proprietary drug delivery platform.
BiotechHealthtechMedical Devices